Enzymatic Therapy
ThymuPlex Immune Formula
Serving
4 Capsule(s)
Per container
12
Form
capsule-unknown
UPC
763948039951
DSLD
Formula hash
8cf4684f91fe
Brand context
Catalog
675
products
With avoid flag
118
products
FDA recalls
0
history
CAERS
5
reports
Avoid-flaggedObjective label signals
Flagged excipients
1
1 avoid · 0 caution
FDA recalls
0
no recall history
CAERS reports
5
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.
Supplement Facts
12 active ingredients| Ingredient | Amount | % DV |
|---|---|---|
| Total Carbohydrates CarbohydrateotherUNII · 0 | 1 Gram(s) | 1% |
| Protein Protein (unspecified)other | 1 Gram(s) | 2% |
| Vitamin A vitaminUNII · 81G40H8B0T UL · set3 effects | 25000 IU | 500% |
| Vitamin C vitaminUNII · PQ6CK8PD0R UL · set5 effects | 250 mg | 417% |
| Vitamin E vitaminUNII · H4N855PNZ1 UL · set1 effect | 200 IU | 667% |
| Zinc mineralUNII · J41CSQ7QDS UL · set8 effects | 15 mg | 100% |
| Selenium mineralUNII · H6241UJ22B UL · set3 effects | 25 mcg | 36% |
| Proprietary Thymus Polypeptide Fractions/Glandular Complex Proprietary Blend (Combination)other | 900 mg | — |
| Echinacea purpurea herbUNII · QI7G114Y98 | 300 mg | — |
| Lysine amino_acidUNII · K3Z4F929H6 | 250 mg | — |
| Fennel herbUNII · 557II4LLC3 | 65 mg | — |
| Goldenseal Root Extract GoldensealherbUNII · ZW3Z11D0JV | 64 mg | — |
What this product supports · authorized claims
13 authority-backed effects
Rolled up from EFSA / FDA / NIH ODS authorized function claims on this product's active ingredients. Each row shows which ingredients contribute.
- from: Selenium · Vitamin A · Vitamin C · Zinc
- from: Selenium
- from: Vitamin A · Zinc
- from: Vitamin A
- from: Vitamin C
- from: Vitamin C
- from: Zinc
- from: Zinc
- from: Zinc
- from: Zinc
- from: Zinc
- from: Selenium · Vitamin C · Vitamin E · Zinc
- from: Vitamin C
Flagged excipients
1 flagged · authority citations
- ● AVOIDTitanium Dioxide colorcolor
Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.
FDA CAERS · adverse event context
5
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.
CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →
Other ingredients
Gelatin · Cellulose · Magnesium Stearate · Silicon Dioxide